Caregen Co., Ltd. (KOSDAQ:214370)

Market Cap	4.55T +266.2%
Revenue (ttm)	72.81B -11.8%
Net Income	20.10B -37.8%
EPS	411.00 -37.5%
Shares Out	48.87M
PE Ratio	226.76
Forward PE	n/a
Dividend	437.00 (0.47%)
Ex-Dividend Date	Dec 29, 2025

Volume	175,907
Average Volume	121,467
Open	94,100
Previous Close	93,200
Day's Range	83,600 - 96,000
52-Week Range	29,800 - 153,800
Beta	n/a
RSI	37.87
Earnings Date	Apr 30, 2026

About Caregen

Caregen Co., Ltd. engages in the development of biomimetic peptides. It operates through the following business divisions: Professional Therapy, Cosmeceutical, Health Functional Food, and Raw Material. The Professional Therapy division develops and sells medical devices that uses functional peptides and sustained release formulation technology systems. The Cosmeceutical division offers products such as skin and hair care, whitening, anti-inflammatory, botulinum toxin function, and hair and scalp care. The Health Functional Food division provide...

• Industry: Chemicals
• Sector: Materials
• Founded: 2001
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214370

Financial Performance

In 2025, Caregen's revenue was 72.81 billion, a decrease of -11.84% compared to the previous year's 82.59 billion. Earnings were 20.10 billion, a decrease of -37.80%.